white-phone-line

+45 53 60 06 70

white-mail-line

Send mail

News

Ossiform - Announces rebrand

By Ossiform | Jan 05, 2022 | NEWS

ODENSE, January 5th, 2022 – Ossiform, We Print Bone™, is pleased to announce that it has completed its rebranding. With the approaching launch of its first bone implant for human use, the Company has rapidly grown and matured, and the rebranding marks a further step in expanding Ossiform’s commercialization activities

Patent for Ossiform’s technology granted in China

by Ossiform | Aug 20, 2021 | NEWS

August 10th 2021, the China National Intellectual Property Administration (CNIPA) announced that Ossiform’s patent, Feedstock for 3D printing and uses thereof no. PCT/DK2016/050323, has been granted in China.

Ossiform – New market-oriented Chairman of the Board

by Ossiform | Jun 1, 2021 | NEWS

ODENSE, 1st June 2021 – Ossiform, We Print Bone™, is pleased to announce that a new and highly qualified Chairman of the Board has been found.

The Company appoints Mette-Marie Harild as new Chairman of the Board if she is elected to the board of directors at Ossiform Limited’s general meeting which will take place on 15th June 2021.

Big step towards market approval and registration: Ossiform initiates QMS implementation

by Ossiform | Dec 14, 2020 | NEWS

December 11th, 2020, Ossiform's executive management signed the first fundamental procedures of the Quality Management System which will lay the foundation for the market approval and registration of the P3D Bone implant in the USA.

The Company has thereby commenced the implementation of a medical device Quality Management System with a view to achieve ISO 13485 certification – the international standard for quality management systems in the medical device industry. This presents a big step towards the establishment of a production in accordance with regulatory and international standards in order to produce P3D Bone implants for human use.

New research article: Treating mouse skull defects with 3D-printed fatty acid and tricalcium phosphate implants

by Ossiform | Nov 13, 2020 | NEWS

The performance of P3D Bone as a novel form of individualized ceramic bone implants and controlled release drug depots has been investigated in previous studies (Jensen et al., 2018; Slots et al., 2017). The results of several laboratory tests and pre-clinical in vivo trials demonstrates that the implants are mechanically strong, free from contaminants, support a rapid formation of new vascularized bone, and integrate with neighboring bone in vivo .

Patent for Ossiform’s technology granted in the USA

by Ossiform | Jun 10, 2020 | NEWS

June 9th 2020, the United States Patent and Trademark office (USPTO) announced that Ossiform’s patent, Feedstock for 3D printing and uses thereof no. PCT/DK2016/050323, has been granted in the USA.

This marks Ossiform’s second patent issuance, following the approval and publication of its European patent, EP/3359318, in April 2020.

Ossiform raises capital through West Hill

by Ossiform | May 18, 2020 | NEWS

ODENSE, May 18th, 2020 – Ossiform, We Print Bone™, is pleased to announce that the £2.5 million capital raise through West Hill Capital was heavily oversubscribed. Ossiform has developed a disruptive and patented technology to be used to produce and supply P3D Bone; 3D printed patient-specific, resorbable bone implants that remodel into real living bone. The first research products have been launched, the P3D Scaffolds, bringing natural bone environments into laboratories.

Ossiform enters U.S. partnership with Asimov Ventures

by Ossiform | May 4, 2020 | NEWS

Ossiform receives investment from New York based venture capital firm, Asimov Ventures, and enters valuable U.S. partnership. The partnership with Asimov Ventures marks the Company’s first step into the U.S. market, looking toward an early commercialization of P3D Bone in the USA.

Ossiform Wins AMS Startup Competition, Boston, 2020

by Ossiform | Feb 13, 2020 | NEWS

Ossiform attended the third annual Additive Manufacturing Strategies summit in Boston which, this year, evolved around the Business of 3D Printing: Medicine, Dentistry and Metals.

On February 11th, 2020, the event’s Startup Competition took place. Here, one seed-stage 3D printing startup focused on either bioprinting, hardware, materials or software has the chance to win a prize of $15,000 from the early stage venture fund Asimov Ventures.

Ossiform Featured in WIRED Magazine

by Ossiform | Feb 13, 2020 | NEWS

Ossiform is featured in a story by WIRED Magazine about our work to develop better, healthier bone implants that remodel into real living bone tissue.

The story was first published in the March / April 2020 issue of WIRED magazine.

Our mission is your benefits

Our mission is to provide 3D printed natural bone implants to reduce complications, improve functional & aesthetic outcomes, and obtain faster recovery.

Natural bone porosity, optimized for bone regeneration

The unique structure of the P3D Bone is designed to facilitate the natural forming of new bone.

Remodels into real living bone

The natural material and structure ensure effective remodeling of the implant into new vascularized bone.

Patient specific - designed with the patient's uniqueness in mind

The P3D Bone is 3D printed to enable a full restoration of the functionality and appearance of bones.

Resorbable material with structural support

P3D Bone eliminates the need to harvest bone as well as the need for permanent and ill-fitting implants.

P3D Bone Void Filler is expected to launch in 2022

Our first 3D printed, resorbable P3D Bone with modifiable dimensions and a lifelike bone architecture

P3D Bone Patient Specific Implant is expected to launch in 2024

Our patient specific and resorbable P3D Bone based on the patient’s own CT/MRI scan data

We Print Bone™

Contact us here

Contact us for questions, general inquiries, or to request a quote.
We strive to provide you with highest quality service and expertise in medical 3D printing.